Phase I/II study of Osimertinib and stereotactic radio surgery in EGFR positive non-small-cell lung cancer with brain metastasis

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/16 → 1/1/21

Funding

  • AstraZeneca: $708,056.00